Cover Image for Defining Value: How Deep Tech Startups Can Frame Their Innovation for the Market
Cover Image for Defining Value: How Deep Tech Startups Can Frame Their Innovation for the Market
Avatar for Nucleate Global Events Calendar
Nucleate is a free, trainee-led 501(c)(3) non-profit organization dedicated to empowering the next generation of biotech leaders.

Defining Value: How Deep Tech Startups Can Frame Their Innovation for the Market

Zoom
Registration
Past Event
Welcome! To join the event, please register below.
About Event

About the Event

Too often, deep tech startups focus on what’s scientifically impressive instead of what’s valuable to customers. In this short seminar, presented by Nucleate Florida, we’ll break down how to define and communicate value in a way that resonates with investors, partners, and non-technical audiences. Perfect for teams preparing for fundraising, pitching, or go-to-market.

About the Speaker - Lisa Voronkova

Lisa Voronkova is the founder and CEO of OVA Solutions, a hardware R&D firm specializing in medtech. Her team has worked on over 150 devices, from orthopedic wearables to diagnostic tools. Lisa helps deep-tech startups translate complex technologies into real-world products and market-ready narratives.

About the Event Host

Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.

Avatar for Nucleate Global Events Calendar
Nucleate is a free, trainee-led 501(c)(3) non-profit organization dedicated to empowering the next generation of biotech leaders.